Credit Suisse Ag Agios Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 111,632 shares of AGIO stock, worth $4.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,632

Previous 109,194 2.23%

Holding current value

$4.69 Million

Previous $2.43 Million 34.27%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$21.32 - $34.81 $51,978 - $84,866	2,438 Added 2.23%	111,632 $3.26 Million
Q4 2023 Feb 08, 2024	BUY	$19.97 - $24.53 $30,614 - $37,604	1,533 Added 1.42%	109,194 $2.43 Million
Q3 2023 Nov 13, 2023	SELL	$24.36 - $28.18 $319,213 - $369,270	-13,104 Reduced 10.85%	107,661 $2.66 Million
Q2 2023 Aug 11, 2023	BUY	$21.38 - $29.19 $391,980 - $535,169	18,334 Added 17.9%	120,765 $3.42 Million
Q1 2023 May 10, 2023	BUY	$21.74 - $30.93 $128,505 - $182,827	5,911 Added 6.12%	102,431 $2.35 Million

Q4 2022 Feb 13, 2023	BUY	$24.81 - $31.52 $207,014 - $263,002	8,344 Added 9.46%	96,520 $2.71 Million
Q3 2022 Nov 10, 2022	BUY	$19.51 - $34.14 $251,698 - $440,440	12,901 Added 17.14%	88,176 $2.49 Million
Q2 2022 Aug 12, 2022	SELL	$17.06 - $31.42 $128,427 - $236,529	-7,528 Reduced 9.09%	75,275 $1.67 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $22,944 - $29,936	-860 Reduced 1.03%	82,803 $2.41 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $17,629 - $29,668	-596 Reduced 0.71%	83,663 $2.75 Million
Q3 2021 Nov 12, 2021	BUY	$41.92 - $58.18 $17,857 - $24,784	426 Added 0.51%	84,259 $3.89 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $1.31 Million - $1.54 Million	-25,105 Reduced 23.05%	83,833 $4.62 Million
Q1 2021 May 14, 2021	SELL	$44.23 - $57.5 $1.5 Million - $1.95 Million	-33,913 Reduced 23.74%	108,938 $5.63 Million
Q4 2020 Feb 12, 2021	BUY	$33.21 - $46.54 $715,276 - $1 Million	21,538 Added 17.75%	142,851 $6.19 Million
Q3 2020 Nov 13, 2020	BUY	$33.87 - $55.93 $378,429 - $624,905	11,173 Added 10.14%	121,313 $4.25 Million
Q2 2020 Aug 12, 2020	BUY	$34.45 - $53.48 $739,400 - $1.15 Million	21,463 Added 24.2%	110,140 $5.89 Million
Q1 2020 May 13, 2020	SELL	$31.52 - $53.81 $489,221 - $835,185	-15,521 Reduced 14.9%	88,677 $3.15 Million
Q4 2019 Feb 12, 2020	BUY	$30.08 - $50.59 $2.02 Million - $3.4 Million	67,215 Added 181.75%	104,198 $4.98 Million
Q3 2019 Nov 12, 2019	SELL	$32.4 - $49.58 $351,896 - $538,488	-10,861 Reduced 22.7%	36,983 $1.2 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $492,772 - $726,831	10,673 Added 28.71%	47,844 $2.39 Million
Q1 2019 May 14, 2019	SELL	$45.92 - $67.67 $260,090 - $383,282	-5,664 Reduced 13.22%	37,171 $2.51 Million
Q4 2018 Feb 13, 2019	BUY	$42.73 - $76.53 $399,311 - $715,172	9,345 Added 27.9%	42,835 $1.97 Million
Q3 2018 Nov 13, 2018	SELL	$71.67 - $91.95 $140,186 - $179,854	-1,956 Reduced 5.52%	33,490 $2.58 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $675,454 - $918,348	-9,225 Reduced 20.65%	35,446 $2.99 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $639,762 - $925,265	10,693 Added 31.47%	44,671 $3.65 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $2.88 Million - $3.99 Million	-55,189 Reduced 61.89%	33,978 $1.94 Million
Q3 2017 Nov 14, 2017	SELL	$54.89 - $67.12 $2.89 Million - $3.53 Million	-52,563 Reduced 37.09%	89,167 $5.95 Million
Q2 2017 Aug 14, 2017	BUY	N/A	141,730	141,730 $7.29 Million

Others Institutions Holding AGIO

# of Institutions

207

Shares Held

60M

Call Options Held

365K

Put Options Held

457K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.31B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account